GlassScriptPhysician profile
Leah Martinson
NPI 1275738106
$1,914.95
in general payments reported to CMS, 2019-2025
22 companies · $210 in 2025
The $210 reported for 2025 was more than what a typical General Practice provider received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $321 · 2020: $36.86 · 2021: $275 · 2022: $356 · 2023: $190 · 2024: $527 · 2025: $210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $926.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $926.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $536.43 | 2021-2025 | Qelbree, Qelbree |
| Ironshore Pharmaceuticals INC. | $272.70 | 2019-2024 | Jornay Pm |
| Sanofi Pasteur INC. | $179.50 | 2019-2025 | |
| Corium, LLC | $148.90 | 2021-2025 | Azstarys |
| Merck Sharp & Dohme LLC | $128.33 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $84.63 | 2021-2022 | |
| Neos Therapeutics, LP | $77.72 | 2021-2024 | Adzenys Xr-Odt |
| Pfizer INC. | $75.24 | 2019-2025 | |
| Kaleo, INC. | $59.47 | 2019-2022 | |
| Shire North American Group INC | $47.04 | 2019 | |
| Genentech USA, INC. | $42.47 | 2019-2020 | |
| Seqirus USA INC | $38.45 | 2022-2025 | Flucelvax |
| Sobi, INC | $36.20 | 2019-2021 | |
| Cranial Technologies, INC | $31.89 | 2023-2025 | Doc Band |
| Tris Pharma INC | $29.06 | 2019-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $22.68 | 2025 | Jornay Pm |
| Sanofi-Aventis U.S. LLC | $21.64 | 2024 | |
| Alexion Pharmaceuticals, INC. | $21.00 | 2019 | |
| Biomerieux INC | $17.51 | 2025 | Biofire Spotfire Control Station |
| Phadia US INC. | $15.12 | 2025 | Immunocap |
| Novo Nordisk INC | $14.89 | 2024 | Wegovy |
| Glaxosmithkline, LLC. | $14.08 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leah Martinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.